MississippiSB 21172026 Regular SessionSenate

Uniform Controlled Substances Act; revise Schedule I.

Sponsored By: Turner-Ford

Signed by Governor

Drug Policy

Your PRIA Score

Score Hidden

Personalized for You

How does this bill affect your finances?

Sign up for a PRIA Policy Scan to see your personalized alignment score for this bill and every other piece of legislation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.

Free to start

Bill Overview

Analyzed Economic Effects

7 provisions identified: 5 benefits, 0 costs, 2 mixed.

Fentanyl-like drugs treated as Schedule I

Beginning July 1, 2026, Mississippi treats many fentanyl-like substances as Schedule I drugs. The law defines fentanyl-related drugs by their chemical structure. Any drug that fits the definition counts as Schedule I unless it is excepted or moved to another schedule. Police and prosecutors can charge these as Schedule I offenses.

More opium derivatives in Schedule I

Beginning July 1, 2026, the law lists more opium derivatives, such as heroin and desomorphine, in Schedule I. Their salts, isomers, and salts of isomers are also covered. These drugs count as Schedule I unless excepted or placed in another schedule.

New drug schedules start July 1, 2026

The law takes effect July 1, 2026. On that date, all Schedule I changes in this act apply statewide.

Stimulants and 'bath salts' in Schedule I

Beginning July 1, 2026, many stimulants and synthetic cathinones are Schedule I. The law defines synthetic cathinones by their chemical structure and lists examples like dipentylone, 4-CMC, alpha-PiHP, 3-MMC, and ethylphenidate. These substances count as Schedule I unless excepted or listed elsewhere.

Synthetic cannabinoids added to Schedule I

Beginning July 1, 2026, synthetic cannabinoids are Schedule I. Any product with any amount of the listed synthetic cannabinoids is covered. The rule applies unless a substance is excepted or put into another schedule.

GHB and other depressants in Schedule I

Beginning July 1, 2026, certain depressants, including GHB (and sodium oxybate), clonazolam, flualprazolam, flubromazolam, and others, are Schedule I. These drugs are treated as Schedule I unless they are excepted or placed in another schedule. This gives law enforcement Schedule I authority over these depressants.

Hallucinogens and THC listed; hemp exempt

Beginning July 1, 2026, many hallucinogens and tetrahydrocannabinols are Schedule I in Mississippi. The law keeps exemptions for hemp regulated under state law and FDA-approved CBD drugs. It also exempts processed cannabis stalks, sterilized seeds in animal feed, some THC industrial materials, and personal-care products with seed oil that do not let THC enter the body. FDA-approved ingestible hemp products remain exempt, and this does not cover dronabinol or nabilone. If an exemption does not apply, the item is treated as Schedule I.

Sponsors & Cosponsors

Sponsor

  • Turner-Ford

    Affiliation unavailable

Cosponsors

There are no cosponsors for this bill.

Roll Call Votes

All Roll Calls

Yes: 172 • No: 0

House vote 3/4/2026

Passed

Yes: 120 • No: 0

Senate vote 2/5/2026

Passed

Yes: 52 • No: 0

Actions Timeline

  1. Approved by Governor

    3/13/2026legislature
  2. Enrolled Bill Signed

    3/9/2026House
  3. Enrolled Bill Signed

    3/9/2026Senate
  4. Returned For Enrolling

    3/5/2026House
  5. Passed

    3/4/2026House
  6. Title Suff Do Pass

    2/26/2026House
  7. Referred To Drug Policy

    2/6/2026House
  8. Transmitted To House

    2/6/2026Senate
  9. Immediate Release

    2/5/2026Senate
  10. Passed

    2/5/2026Senate
  11. Title Suff Do Pass

    1/29/2026Senate
  12. Referred To Drug Policy

    1/9/2026Senate

Bill Text

Related Bills

Back to State Legislation